Skip to main content

BIOS Fund I, LP's Form 4 filing

Lantern Pharma Inc. (LTRN) · filed Jun 13, 2025

Accession no.
0001104659-25-059106
Filed
Jun 13, 2025, 6:06 AM ET
Trade date
Jun 10-12, 2025
Filing delay
3 daysLate
Rule 10b5-1 plan
Not checked

This filing lists 15 non-derivative transactions and 0 derivative transactions. Open-market sales total $208.3K. It was filed 3 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
BIOS Fund I, LPCIK 000169731610% Owner
BIOS Fund I QP, LPCIK 000170029710% Owner
BIOS Fund II, LPCIK 000171457610% Owner
BIOS Fund II QP, LPCIK 000171686910% Owner
BIOS Fund II NT, LPCIK 000172885110% Owner
Fletcher Aaron G.L.CIK 000178949010% Owner
Bios Equity Partners II, LPCIK 000181331310% Owner
Bios Equity Partners, LPCIK 000181331410% Owner
BIOS Advisors GP, LLCCIK 000181384410% Owner
BIOS Capital Management, LPCIK 000181384510% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 10, 2025Common StockSSaleDisposed−3$3.40−$10.2207,419IndirectDuplicate filing
Jun 11, 2025Common StockSSaleDisposed−171$3.40−$581.4207,248IndirectDuplicate filing
Jun 12, 2025Common StockSSaleDisposed−10,925$3.38−$36,926.5196,323IndirectDuplicate filing
Jun 10, 2025Common StockSSaleDisposed−5$3.40−$17354,625IndirectDuplicate filing
Jun 11, 2025Common StockSSaleDisposed−293$3.40−$996.2354,332IndirectDuplicate filing
Jun 12, 2025Common StockSSaleDisposed−18,678$3.38−$63,131.64335,654IndirectDuplicate filing
Jun 10, 2025Common StockSSaleDisposed−1$3.40−$3.454,791IndirectDuplicate filing
Jun 11, 2025Common StockSSaleDisposed−45$3.40−$15354,746IndirectDuplicate filing
Jun 12, 2025Common StockSSaleDisposed−2,886$3.38−$9,754.6851,860IndirectDuplicate filing
Jun 10, 2025Common StockSSaleDisposed−5$3.40−$17409,291IndirectDuplicate filing
Jun 11, 2025Common StockSSaleDisposed−338$3.40−$1,149.2408,953IndirectDuplicate filing
Jun 12, 2025Common StockSSaleDisposed−21,557$3.38−$72,862.66387,396IndirectDuplicate filing
Jun 10, 2025Common StockSSaleDisposed−2$3.40−$6.8125,330IndirectDuplicate filing
Jun 11, 2025Common StockSSaleDisposed−103$3.40−$350.2125,227IndirectDuplicate filing
Jun 12, 2025Common StockSSaleDisposed−6,601$3.38−$22,311.38118,626IndirectDuplicate filing

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)